Adriana Olar

Adriana Olar

UNVERIFIED PROFILE

Are you Adriana Olar?   Register this Author

Register author
Adriana Olar

Adriana Olar

Publications by authors named "Adriana Olar"

Are you Adriana Olar?   Register this Author

44Publications

-Reads

Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.

Oncotarget 2018 Jun 19;9(47):28652-28665. Epub 2018 Jun 19.

Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, 75390, TX, USA.

View Article
June 2018

DNA methylation-based classification of central nervous system tumours.

Authors:
David Capper David T W Jones Martin Sill Volker Hovestadt Daniel Schrimpf Dominik Sturm Christian Koelsche Felix Sahm Lukas Chavez David E Reuss Annekathrin Kratz Annika K Wefers Kristin Huang Kristian W Pajtler Leonille Schweizer Damian Stichel Adriana Olar Nils W Engel Kerstin Lindenberg Patrick N Harter Anne K Braczynski Karl H Plate Hildegard Dohmen Boyan K Garvalov Roland Coras Annett Hölsken Ekkehard Hewer Melanie Bewerunge-Hudler Matthias Schick Roger Fischer Rudi Beschorner Jens Schittenhelm Ori Staszewski Khalida Wani Pascale Varlet Melanie Pages Petra Temming Dietmar Lohmann Florian Selt Hendrik Witt Till Milde Olaf Witt Eleonora Aronica Felice Giangaspero Elisabeth Rushing Wolfram Scheurlen Christoph Geisenberger Fausto J Rodriguez Albert Becker Matthias Preusser Christine Haberler Rolf Bjerkvig Jane Cryan Michael Farrell Martina Deckert Jürgen Hench Stephan Frank Jonathan Serrano Kasthuri Kannan Aristotelis Tsirigos Wolfgang Brück Silvia Hofer Stefanie Brehmer Marcel Seiz-Rosenhagen Daniel Hänggi Volkmar Hans Stephanie Rozsnoki Jordan R Hansford Patricia Kohlhof Bjarne W Kristensen Matt Lechner Beatriz Lopes Christian Mawrin Ralf Ketter Andreas Kulozik Ziad Khatib Frank Heppner Arend Koch Anne Jouvet Catherine Keohane Helmut Mühleisen Wolf Mueller Ute Pohl Marco Prinz Axel Benner Marc Zapatka Nicholas G Gottardo Pablo Hernáiz Driever Christof M Kramm Hermann L Müller Stefan Rutkowski Katja von Hoff Michael C Frühwald Astrid Gnekow Gudrun Fleischhack Stephan Tippelt Gabriele Calaminus Camelia-Maria Monoranu Arie Perry Chris Jones Thomas S Jacques Bernhard Radlwimmer Marco Gessi Torsten Pietsch Johannes Schramm Gabriele Schackert Manfred Westphal Guido Reifenberger Pieter Wesseling Michael Weller Vincent Peter Collins Ingmar Blümcke Martin Bendszus Jürgen Debus Annie Huang Nada Jabado Paul A Northcott Werner Paulus Amar Gajjar Giles W Robinson Michael D Taylor Zane Jaunmuktane Marina Ryzhova Michael Platten Andreas Unterberg Wolfgang Wick Matthias A Karajannis Michel Mittelbronn Till Acker Christian Hartmann Kenneth Aldape Ulrich Schüller Rolf Buslei Peter Lichter Marcel Kool Christel Herold-Mende David W Ellison Martin Hasselblatt Matija Snuderl Sebastian Brandner Andrey Korshunov Andreas von Deimling Stefan M Pfister

Nature 2018 03 14;555(7697):469-474. Epub 2018 Mar 14.

Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.

View Article
March 2018

A gene expression signature predicts recurrence-free survival in meningioma.

Oncotarget 2018 Mar 15;9(22):16087-16098. Epub 2018 Feb 15.

The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, TX, USA.

View Article
March 2018

Ependymomas arising outside of the central nervous system: A case series and literature review.

J Clin Neurosci 2018 Jan 18;47:202-207. Epub 2017 Oct 18.

Neuro-Oncology Branch, National Institutes of Health, United States.

View Article
January 2018

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Cancer Cell 2017 07;32(1):42-56.e6

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address:

View Article
July 2017

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.

Acta Neuropathol 2017 Mar 27;133(3):431-444. Epub 2017 Jan 27.

Princess Margaret Cancer Centre, MacFeeters-Hamilton Brain Tumour Centre, College Street 101, Toronto, M5G 1L7, ON, Canada.

View Article
March 2017

Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas.

J Pathol Inform 2017 10;8. Epub 2017 Mar 10.

Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article
March 2017

Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution.

Ann Surg Oncol 2016 12 19;23(Suppl 5):962-967. Epub 2016 Sep 19.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
December 2016

Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups.

Neuro Oncol 2016 06 28;18(6):790-6. Epub 2016 Jan 28.

Institute of Neuropathology, University Hospital Münster, Münster, Germany (C.T., V.R., A.J., W.P., M.H.); Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany (M.S.); Core Facility Genomics of the Medical Faculty Münster, Münster, Germany (A.W.); Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.H., U.K.); Department of Neuropathology, Institute for Pathology and Neuropathology, University of Tübingen, Tübingen, Germany (R.B.); Faculty of Medicine, Institute of Neuropathology, University of Duisburg-Essen, Essen, Germany (K.K.); Department of Neuropathology, Klinikum Bremen-Mitte, Bremen, Germany (M.B.); Institute of Neurology (Edinger Institute), Goethe University, Frankfurt, Germany (M.M.); Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany (T.P.); Department of Neuropathology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany (J.F.); Department of Neuropathology, Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken (CCCM), Würzburg, Germany (C.M.M.); Department of Neuropathology, Sainte-Anne Hospital, Paris, France (P.V.); 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary (P.H.); Department of Hematopathology, Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.O.); Children's Brain Tumour Research Centre, School of Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK (R.G.G.); Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic Children's Hospital, Cleveland, Ohio (J.E.W.); Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany (A.K., A.v.D., D.C.); Clinical Cooperation Unit Neuropathology, German Research Center (DKFZ), Heidelberg, Germany (A.K., A.v.D., D.C.); German Cancer Consortium (DKTK), German Cancer Research Ce

View Article
June 2016

Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.

Am J Surg Pathol 2016 06;40(6):847-56

*Department of Pathology †Department of Hematopathology, Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX §Department of Pathology, Third Military Medical University, Chongqing ∥Department of Pathology, Shanghai Cancer Hospital, Fudan University, Shanghai ¶Department of Pathology, The Fourth Military Medical University, Xi'an Departments of ‡Obstetrics and Gynecology #Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

View Article
June 2016

TERT Promoter Mutations and Risk of Recurrence in Meningioma.

J Natl Cancer Inst 2016 May 13;108(5). Epub 2015 Dec 13.

Affiliations of authors:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg , Heidelberg , Germany (FS, DS, CK, DR, JB, AK, DC, SS, AvD); Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg , Germany (FS, DS, CK, DR, AK, DC, AvD); Department of Pathology (AO), Department of Genomic Medicine (QW), Department of Radiation Oncology (QW, EPS), and Department of Bioinformatics and Computational Biology (QW), The University of Texas MD Anderson Cancer Center , Houston, TX ; Department of Radiation Oncology (SA, JD) and Department of Neurosurgery (MSc, TU, CHM), University Hospital Heidelberg , Heidelberg , Germany ; Department of Neuropathology, Charité Medical University , Berlin , Germany (AK); Department of Pathology, University Hospital Nürnberg , Nürnberg , Germany (AFO): Department of Neurosurgery, Medical Faculty of the Ruprecht-Karls-University of Heidelberg , Mannheim , Germany (SB); Department of Neuropathology, Institute of Pathology and Neuropathology, University Tübingen , Tübingen , Germany (JS); Department of Neuropathology, University of Bonn , Bonn , Germany (AB); Department of Neurosurgery (BB) and Institute of Neuropathology (WP), University Hospital Münster , Münster , Germany (BB); Department of Neurosurgery, University Hospital Bonn , Bonn , Germany (KG, MSi); Department of Neurosurgery, University Hospital Würzburg , Würzburg , Germany (AFK); Department of Neurosurgery, University Hospital Hamburg , Hamburg , Germany (KL); Department of Neuropathology, Otto von Guericke University Magdeburg , Magdeburg , Germany (CM); Institute of Pathology, Saarland University , Homburg, Saarland , Germany (YJK); Department of Neurosurgery, Saarland University , Homburg , Germany (RK); MacFeeters-Hamilton Brain Tumour Centre, Princess Margaret Cancer Center , Toronto, Ontario , Canada (KDA); Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg , Germany (TH).

View Article
May 2016

Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature.

J Neurooncol 2016 Mar 30;127(1):155-63. Epub 2015 Dec 30.

Department of Pediatrics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 87, Houston, TX, 77030, USA.

View Article
March 2016

Next-generation sequencing of central nervous systems tumors: the future of personalized patient management.

Neuro Oncol 2016 Mar;18(3):308-10

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (L.Y.B.); Department of Hematopathology, Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.O.); Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (S.R.-C.).

View Article
March 2016

Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

J Neurooncol 2015 Nov 9;125(2):401-10. Epub 2015 Sep 9.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article
November 2015

Corticosteroid sensitivity in gliomatosis cerebri delays diagnosis.

Pract Neurol 2015 Aug 28;15(4):309-11. Epub 2015 Apr 28.

Department of Neuro-Oncology, The University of Texas-M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article
August 2015

Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification.

Semin Radiat Oncol 2015 Jul 23;25(3):155-63. Epub 2015 Feb 23.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article
July 2015

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Brain Pathol 2015 May 29;25(3):266-75. Epub 2014 Oct 29.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article
May 2015

Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.

Authors:
Adriana Olar

Neuro Oncol 2015 May 25;17(5):631-3. Epub 2015 Mar 25.

Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article
May 2015

C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.

Brain Tumor Pathol 2015 Apr 12;32(2):105-11. Epub 2014 Nov 12.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA,

View Article
April 2015

Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis.

J Clin Neurosci 2015 Mar 31;22(3):605-7. Epub 2014 Oct 31.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Room FC7.3000, Unit 431, Houston, TX 77030, USA.

View Article
March 2015

Primary brain tumors and posterior reversible encephalopathy syndrome.

Neurooncol Pract 2014 Dec 14;1(4):184-190. Epub 2014 Sep 14.

Department of Neuro-Oncology , The University of Texas MD Anderson Cancer Center , Houston, Texas (C.K.-M., D.C., T.S.A., M.R.G.); Department of Family Health , The University of Texas Health Science Center School of Nursing , Houston, Texas (T.S.A.); Department of Pathology , The University of Texas MD Anderson Cancer Center , Houston, Texas (A.O.).

View Article
December 2014

Lambrolizumab induced central nervous system (CNS) toxicity.

J Neurol Sci 2014 Sep 20;344(1-2):229-31. Epub 2014 Jun 20.

The University of Texas MD Anderson Cancer Center, Department of Neuro-Oncology, 1515 Holcombe Blvd Unit 431, Houston, TX 77030-4009, United States; The University of Texas MD Anderson Cancer Center, Department of Pathology, 1515 Holcombe Blvd, Houston, TX 77030-4009, United States.

View Article
September 2014

Biologic correlates and significance of axonogenesis in prostate cancer.

Hum Pathol 2014 Jul 28;45(7):1358-64. Epub 2014 Feb 28.

Department of Pathology and Laboratory Medicine, The University of Texas Health Sciences Center at Houston, Medical School, Houston, TX 77030. Electronic address:

View Article
July 2014

Biological correlates of prostate cancer perineural invasion diameter.

Hum Pathol 2014 Jul 28;45(7):1365-9. Epub 2014 Feb 28.

Department of Pathology and Laboratory Medicine, The University of Texas Health Sciences Center at Houston, Medical School, Houston, TX 77030. Electronic address:

View Article
July 2014

The CT halo sign in invasive aspergillosis.

Clin Case Rep 2014 Jun 28;2(3):113-4. Epub 2014 Apr 28.

Department of Neuro-oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, 77030.

View Article
June 2014

Clinical and prognostic features of adult patients with gangliogliomas.

Neuro Oncol 2014 Mar 4;16(3):409-13. Epub 2013 Dec 4.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (S.Y.-K., D.L., J.F.de-G.); Department of Neurology, The University of Mississippi Medical Center, Jackson, Mississippi (M.D.A.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas (J.W., Y.Y.); Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.O., G.N.F.); Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (P.D.B.).

View Article
March 2014

Olfactory colloid cyst: case report and review of extraventricular colloid cyst literature.

World Neurosurg 2014 Jan 2;81(1):202.e19-22. Epub 2013 Aug 2.

Methodist Neurological Institute, Houston, Texas, USA.

View Article
January 2014

Using the molecular classification of glioblastoma to inform personalized treatment.

J Pathol 2014 Jan;232(2):165-77

Department of Pathology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.

View Article
January 2014

Molecular classification of diffuse gliomas.

Oncology (Williston Park) 2013 Jun;27(6):514, 518, 520

Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, Texas, USA.

View Article
June 2013

Biomarkers classification and therapeutic decision-making for malignant gliomas.

Curr Treat Options Oncol 2012 Dec;13(4):417-36

Department of Pathology and Genomic Medicine, The Methodist Hospital, 6565 Fannin St, M227, Houston, TX 77030, USA.

View Article
December 2012

Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.

Ann Diagn Pathol 2012 Aug 23;16(4):255-9. Epub 2012 Mar 23.

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA.

View Article
August 2012

Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.

Ann Diagn Pathol 2012 Jun 24;16(3):161-70. Epub 2011 Dec 24.

Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, TX, USA.

View Article
June 2012

Myxoid liposarcoma: a case report of a sentinel metastasis to the parotid gland with molecular confirmation.

Diagn Cytopathol 2011 Oct;39(10):780-3

Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article
October 2011